Eagle Bay Advisors LLC Viatris Inc Transaction History

Eagle Bay Advisors LLC

$157 Million
Q4 2024

A detailed history of Eagle Bay Advisors LLC transactions in Viatris Inc stock. As of the latest transaction made, Eagle Bay Advisors LLC holds 266 shares of VTRS stock, worth $2,566. This represents 0.0% of its overall portfolio holdings.

Number of Shares

266

Previous 278 4.32%

Holding current value

$2,566

Previous $3,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 13, 2025	SELL	$11.32 - $13.37 $135 - $160	-12 Reduced 4.32%	266 $3,000
Q3 2024 Oct 22, 2024	SELL	$10.32 - $12.13 $288 - $339	-28 Reduced 9.15%	278 $3,000
Q2 2024 Jul 26, 2024	BUY	$10.05 - $12.02 $10 - $12	1 Added 0.33%	306 $3,000
Q3 2023 Nov 13, 2023	BUY	$9.59 - $11.35 $9 - $11	1 Added 0.33%	305 $3,000
Q2 2023 Aug 10, 2023	SELL	$9.02 - $10.29 $649 - $740	-72 Reduced 19.15%	304 $3,000
Q1 2023 Apr 24, 2023	SELL	$9.2 - $12.26 $5,547 - $7,392	-603 Reduced 61.59%	376 $3,000
Q4 2022 Jan 26, 2023	SELL	$8.72 - $11.56 $32,813 - $43,500	-3,763 Reduced 79.35%	979 $0
Q3 2022 Nov 22, 2022	BUY	$8.48 - $11.13 $10,676 - $14,012	1,259 Added 36.15%	4,742 $41,000
Q2 2022 Aug 19, 2022	BUY	$9.95 - $12.27 $32,108 - $39,595	3,227 Added 1260.55%	3,483 $36.5 Million
Q1 2022 May 11, 2022	SELL	$9.81 - $15.4 $33,677 - $52,868	-3,433 Reduced 93.06%	256 $3,000
Q4 2021 Jan 21, 2022	BUY	$12.09 - $14.68 $17,191 - $20,874	1,422 Added 62.73%	3,689 $50,000
Q3 2021 Nov 12, 2021	BUY	$13.25 - $15.13 $6,717 - $7,670	507 Added 28.81%	2,267 $30,000
Q2 2021 Jul 30, 2021	BUY	$12.97 - $16.15 $22,827 - $28,423	1,760 New	1,760 $31,000

Others Institutions Holding VTRS

# of Institutions

1,140

Shares Held

988M

Call Options Held

2.34M

Put Options Held

2.21M

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $11.7B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Bay Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Bay Advisors LLC with notifications on news.

Account

Eagle Bay Advisors LLC Viatris Inc Transaction History